M&A news

UPL Acquires HGS BioScience to Boost Bio

HGS BioScience acquired by UPL

AcquisitionManufacturingUS

Get the full HGS BioScience company profile

Access contacts, investors, buying signals & more

Open in Dashboard
HGS BioScience logo
Acquired

HGS BioScience

United StatesManufacturing

Undisclosed amount

January 19, 2026

UPL logo
Acquirer

UPL

UPL has acquired HGS BioScience, a company specializing in soil health solutions, for an undisclosed amount. This acquisition marks a significant expansion for UPL into the advanced biological inputs sector. HGS BioScience is recognized for its innovative and patented extracted humates delivery platforms, designed to enhance soil health and maximize crop yield potential.

HGS BioScience operates as a world-class manufacturer of patent-protected extracted humate products. These products are engineered to improve soil health and crop performance by unlocking soil nutrients, increasing organic matter and water holding capacity, and reducing plant stress. The company's proprietary process involves extracting humic substances into a liquid, flash-drying it into a powder, and formulating it into patented granules, which offer superior soil health benefits compared to raw humic acid. Headquartered in north Jacksonville, FL, HGS BioScience maintains five additional facilities across the US and Canada.

The acquisition is strategically aligned with UPL's objective to strengthen its portfolio of sustainable agricultural solutions. By integrating HGS BioScience's advanced humate technology, UPL aims to provide growers with a broader range of tools to improve soil fertility and crop resilience. This move allows UPL to capitalize on the growing demand for biological and environmentally friendly agricultural inputs that contribute to sustainable farming practices.

Expected synergies include leveraging UPL's global distribution network to expand the reach of HGS BioScience's products to new markets worldwide. UPL will gain access to HGS BioScience's proprietary manufacturing processes and patented formulations, enhancing its offering in the soil health segment. Conversely, HGS BioScience will benefit from UPL's extensive market presence and resources, accelerating the adoption of its innovative humate products.

The combined entity is poised to deliver comprehensive solutions that address critical challenges in modern agriculture, focusing on enhancing productivity while promoting environmental stewardship. This integration is expected to drive innovation in soil health management and sustainable crop production on a global scale.

No buying signals identified yet.

Unlock GTM signals

Discover HGS BioScience's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at HGS BioScience.

Unlock decision-makers